Associate Professor Rhiannon Braund
| Position | Associate Professor |
|---|---|
| Department | Department of Preventive and Social Medicine |
| Qualifications | BSc BPharm PhD(Otago) FPS FNZCP RegPharmNZ |
| Research summary | Safe and effective use of medicines; Clinical pharmacy practice |
| Teaching | I received the Prime Minister’s Supreme Award for Excellence in Tertiary Teaching in 2012. Currently my teaching focus is on postgraduate research. |
| Clinical | In 2018 I was made a Fellow of the New Zealand Pharmaceutical Society for my work in advancement of the profession. I am currently an elected member of the National Executive of the Pharmaceutical Society of New Zealand. |
Research
Safe Use of Medicines: My role at the NZ Pharmacovigilance Centre is to identify the adverse effects of medicines (and related substances) to provide evidence regarding the safe use of medicines and to identify how to best optimise the safe and effective use of medicines for patients.
As an academic pharmacist and practitioner, the role that pharmacists play in the delivery of medicine rationalisation, optimisation, and safety are at the centre of my research. My research in advanced clinical pharmacy practice has had significant local and international influence in the service delivery and enhanced patient outcomes arena.
This work extends to transition of care points and collaborative team approaches to medicine use and patient safety.
Publications
Braund, R., Lawrence, C. K., Baum, L., Kessler, B., Vassart, M., & Coulter, C. (2019). Quality of electronic records documenting adverse drug reactions within a hospital setting: Identification of discrepancies and information completeness. New Zealand Medical Journal, 132(1488), 28-37. Retrieved from https://www.nzma.org.nz/journal
Wheeler, B. J., Braund, R., Galland, B., Mikuscheva, A., Wiltshire, E., Jefferies, C., & de Lange, M. (2019). District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes. New Zealand Medical Journal, 132(1491), 78-89. Retrieved from https://www.nzma.org.nz/journal
Napier, P., Norris, P., Green, J., & Braund, R. (2018). Experiences of pharmacy staff during the introduction of the checking technician role in New Zealand. International Journal of Pharmacy Practice. Advance online publication. doi: 10.1111/ijpp.12483
Napier, P., Norris, P., & Braund, R. (2018). Introducing a checking technician allows pharmacists to spend more time on patient focused activities. Research in Social & Administrative Pharmacy, 14(4), 382-386. doi: 10.1016/j.sapharm.2017.05.002
Kharjul, M., Braund, R., & Green, J. (2018). The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes. International Journal of Clinical Pharmacy, 40(2), 354-359. doi: 10.1007/s11096-018-0606-z
Authored Book - Research
Peake, B. M., Braund, R., Tong, A. Y. C., & Tremblay, L. A. (2016). The life-cycle of pharmaceuticals in the environment. Cambridge, UK: Woodhead Publishing, 261p.
Chapter in Book - Research
Braund, R., & Medlicott, N. J. (2013). Biomaterials as platforms for topical administration of therapeutic agents in cutaneous wound healing. In S. Dumitriu & V. Popa (Eds.), Polymeric biomaterials: Structure and function. (pp. 837-850). Boca Raton, FL: CRC Press.
Braund, R., & Peake, B. (2012). Human pharmaceuticals of potential concern to the New Zealand environment. In J. R. Barker & R. Walters (Eds.), New Zealand and Australia in focus: Economics, the environment and issues in health care. (pp. 1-33). New York, NY: Nova Science.
Journal - Research Article
Braund, R., Lawrence, C. K., Baum, L., Kessler, B., Vassart, M., & Coulter, C. (2019). Quality of electronic records documenting adverse drug reactions within a hospital setting: Identification of discrepancies and information completeness. New Zealand Medical Journal, 132(1488), 28-37. Retrieved from https://www.nzma.org.nz/journal
Wheeler, B. J., Braund, R., Galland, B., Mikuscheva, A., Wiltshire, E., Jefferies, C., & de Lange, M. (2019). District health board of residence, ethnicity and socioeconomic status all impact publicly funded insulin pump uptake in New Zealand patients with type 1 diabetes. New Zealand Medical Journal, 132(1491), 78-89. Retrieved from https://www.nzma.org.nz/journal
Napier, P., Norris, P., Green, J., & Braund, R. (2018). Experiences of pharmacy staff during the introduction of the checking technician role in New Zealand. International Journal of Pharmacy Practice. Advance online publication. doi: 10.1111/ijpp.12483
Kharjul, M., Braund, R., & Green, J. (2018). The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes. International Journal of Clinical Pharmacy, 40(2), 354-359. doi: 10.1007/s11096-018-0606-z
Napier, P., Norris, P., & Braund, R. (2018). Introducing a checking technician allows pharmacists to spend more time on patient focused activities. Research in Social & Administrative Pharmacy, 14(4), 382-386. doi: 10.1016/j.sapharm.2017.05.002
Braund, R., Ratnayake, K., Tong, K., Song, J., Chai, S., & Gauld, N. (2018). Pharmacist supply of sildenafil: Pharmacist's experiences and perceptions on training and tools for supply. International Journal of Clinical Pharmacy, 40(3), 650-658. doi: 10.1007/s11096-018-0622-z
Campbell, C., Braund, R., & Morris, C. (2017). Beyond the four walls: An exploratory survey of location, employment and roles of pharmacists in primary health care. Journal of Primary Health Care, 9(4), 297-310. doi: 10.1071/HC17022
Braund, R., Henderson, E., McNab, E., Sarten, R., Wallace, E., & Gauld, N. (2016). Pharmacist-only trimethoprim: Pharmacist satisfaction on their training and the impact on their practice. International Journal of Clinical Pharmacy, 38(6), 1357-1361. doi: 10.1007/s11096-016-0388-0
Assawasuwannakit, P., Braund, R., & Duffull, S. B. (2016). A framework for quantifying the influence of adherence and dose individualization. Clinical Pharmacology & Therapeutics, 99(4), 452-459. doi: 10.1002/cpt.268
Campbell, C., Morris, C., & Braund, R. (2016). Medicines information in New Zealand: Current services and future potential. New Zealand Medical Journal, 129(1447), 21-28. Retrieved from http://www.nzma.org.nz/journal
Napier, P., Norris, P., Green, J., & Braund, R. (2016). Can they do it? Comparing the views of pharmacists and technicians to the introduction of an advanced technician role. International Journal of Pharmacy Practice, 24, 97-103. doi: 10.1111/ijpp.12225
Shen, W., Wong, B., Chin, J. Y. P., Lee, M., Coulter, C., & Braund, R. (2016). Comparison of documentation of patient reported adverse drug reactions on both paper-based medication charts and electronic medication charts at a New Zealand hospital. New Zealand Medical Journal, 129(1444), 90-96. Retrieved from http://www.nzma.org.nz/journal
Napier, P., Norris, P., & Braund, R. (2015). Could it be done safely? Pharmacists views on safety and clinical outcomes from the introduction of an advanced role for technicians. Research in Social & Administrative Pharmacy, 11(6), 814-823. doi: 10.1016/j.sapharm.2014.12.005
Assawasuwannakit, P., Braund, R., & Duffull, S. B. (2015). A model-based meta-analysis of the influence of factors that impact adherence to medications. Journal of Clinical Pharmacy & Therapeutics, 40(1), 24-31. doi: 10.1111/jcpt.12219
Assawasuwannakit, P., Braund, R., & Duffull, S. B. (2015). Quantification of the forgiveness of drugs to imperfect adherence. CPT: Pharmacometrics & Systems Pharmacology, 4(3), 204-211. doi: 10.1002/psp4.4
Santoke, H., Tong, A. Y. C., Mezyk, S. P., Johnston, K. M., Braund, R., Cooper, W. J., & Peake, B. M. (2015). UV photodegradation of enoxacin in water: Kinetics and depradation Pathways. Journal of Environmental Engineering, 141(10), 04015027. doi: 10.1061/(asce)ee.1943-7870.0000954
Braund, R., Coulter, C. V., Bodington, A. J., Giles, L. M., Greig, A.-M., Heaslip, L. J., & Marshall, B. J. (2014). Drug related problems identified by community pharmacists on hospital discharge prescriptions in New Zealand. International Journal of Clinical Pharmacy, 36(3), 498-502. doi: 10.1007/s11096-014-9935-8
Hatah, E., Braund, R., Tordoff, J., & Duffull, S. B. (2014). A systematic review and meta-analysis of pharmacist-led fee-for-services medication review. British Journal of Clinical Pharmacology, 77(1), 102-115. doi: 10.1111/bcp.12140
Hatah, E., Tordoff, J., Duffull, S. B., & Braund, R. (2014). Pharmacists' performance of clinical interventions during adherence support medication reviews. Research in Social & Administrative Pharmacy, 10(1), 185-194. doi: 10.1016/j.sapharm.2013.04.008
Hatah, E., Tordoff, J., Duffull, S. B., Cameron, C., & Braund, R. (2014). Retrospective examination of selected outcomes of Medicines Use Review (MUR) services in New Zealand. International Journal of Clinical Pharmacy, 36(3), 503-512. doi: 10.1007/s11096-014-9913-1
Hatah, E., Braund, R., Duffull, S. B., & Tordoff, J. (2013). General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand. Journal of Primary Health Care, 5(3), 223-233.
Maxwell, K., Harrison, J., Scahill, S., & Braund, R. (2013). Identifying drug-related problems during transition between secondary and primary care in New Zealand. International Journal of Pharmacy Practice, 21(5), 333-336. doi: 10.1111/ijpp.12013
Fan, A. Y., Liu, A. H. C., Pan, B., Yang, C., Coulter, C. V., Shieffelbien, L., Temple, W., & Braund, R. (2013). Investigating childhood and adolescence poisoning exposures in New Zealand reported to the National Poisons Centre during 2000-2009. Asia Pacific Journal of Medical Toxicology, 2(2), 52-57.
Hatah, E., Braund, R., Duffull, S., & Tordoff, J. (2012). General practitioners' perceptions of pharmacists' new services in New Zealand. International Journal of Clinical Pharmacy, 34(2), 364-373. doi: 10.1007/s11096-012-9617-3
Braund, R., Chesney, K. M., Keast, E. P., Ng, L. J., Qi, S., Samaranayaka, S., & Wang, E. (2012). Are all pharmacy staff interested in potential future roles? International Journal of Pharmacy Practice, 20(6), 417-421. doi: 10.1111/j.2042-7174.2012.00216.x
Tong, A. Y. C., Braund, R., Warren, D. S., & Peake, B. M. (2012). TiO2-assisted photodegradation of pharmaceuticals: A review. Central European Journal of Chemistry, 10(4), 989-1027. doi: 10.2478/s11532-012-0049-7
Chang, S. Y., Horsburgh, S., Norris, P., & Braund, R. (2011). Recruitment and retention of primary care patients into a research study investigating medication adherence. Journal of Primary Health Care, 3(3), 204-209.
Tong, A. Y. C., Peake, B. M., & Braund, R. (2011). Disposal practices for unused medications in New Zealand community pharmacies. Journal of Primary Health Care, 3(3), 197-203.
Tong, A. Y. C., Braund, R., Tan, E. W., Tremblay, L. A., Stringer, T., Trought, K., & Peake, B. M. (2011). UV-induced photodegradation of oseltamivir (Tamiflu) in water. Environmental Chemistry, 8(2), 182-189. doi: 10.1071/EN10095
Braund, R., & Abbott, J. H. (2011). Nonsteroidal antiinflammatory drugs (NSAIDS) and paracetamol for acute musculoskeletal injuries: Physiotherapists' understanding of which is safer, more effective, and when to initiate treatment. Physiotherapy Theory & Practice, 27(7), 482-491. doi: 10.3109/09593985.2010.527430
Braund, R., & Abbott, J. H. (2011). Recommending NSAIDs and paracetamol: A survey of New Zealand physiotherapists' knowledge and behaviours. Physiotherapy Research International, 16(1), 43-49. doi: 10.1002/pri.472
Bushby, S. K., Anderson, R. J., & Braund, R. (2010). New Zealand parent's perceptions of the use and safety of over the counter liquid analgesics. Pharmacy Practice, 8(4), 238-242.
Tong, A. Y. C., Peake, B. M., & Braund, R. (2010). Disposal practices for unused medications around the world. Environment International, 37, 292-298. doi: 10.1016/j.envint.2010.10.002
Braund, R., Furlan, H. M., George, K., Havell, M. M. A., Murphy, J. L., & West, M. K. (2010). Interventions performed by New Zealand community pharmacists while dispensing prescription medications. Pharmacy World & Science, 32, 22-25. doi: 10.1007/s11096-009-9343-7
Braund, R., Gn, G., & Matthews, R. (2009). Investigating unused medications in New Zealand. Pharmacy World & Science, 31(6), 664-669. doi: 10.1007/s11096-009-9325-9
Lee, E., Braund, R., & Tordoff, J. (2009). Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008. New Zealand Medical Journal, 122(1293). Retrieved from http://journal.nzma.org.nz/journal/122-1293/3560/content.pdf
Braund, R., Peake, B. M., & Shieffelbien, L. (2009). Disposal practices for unused medications in New Zealand. Environment International, 35(6), 952-955.
Peake, B. M., & Braund, R. (2009). Environmental aspects of the disposal of pharmaceuticals in New Zealand. Chemistry in New Zealand, 73(2), 58-63.
Braund, R., Hook, S. M., Greenhill, N., & Medlicott, N. J. (2009). Distribution of fibroblast growth factor-2 (FGF-2) within model excisional wounds following topical application. Journal of Pharmacy & Pharmacology, 61(2), 193-200. doi: 10.1211/jpp/61.02.0008
James, T. H., Helms, M. L., & Braund, R. (2009). Analysis of medications returned to community pharmacies. Annals of Pharmacotherapy, 43(10), 1631-1635. doi: 10.1345/aph.1M209
Braund, R., Chuah, F., Gilbert, R., Gn, G., Soh, A., Tan, L. Y., Tiong, H. S., & Yuen, Y.-C. (2008). Identification of the reasons for medication returns. New Zealand Family Physician, 35(4), 248-252.
Braund, R., Yuen, Y. C., & Jung, J. (2007). Identification and quantification of medication returned to Otago pharmacies. New Zealand Family Physician, 34, 258-262.
Braund, R., Tucker, I. G., & Medlicott, N. J. (2007). Hypromellose films for the delivery of growth factors for wound healing. Journal of Pharmacy & Pharmacology, 59(3), 367-372.
Braund, R., Bannerman, S. L., Lim, C., Moon, J., Nicholls, J., Straight, P., & Thompson, M. (2006). Recommendations of community pharmacists for the treatment of sprains and strains. International Journal of Pharmacy Practice, 14, 271-276.
Journal - Research Other
Nicholls, J., MacKenzie, C., & Braund, R. (2017). Preventing drug-related adverse events following hospital discharge: The role of the pharmacist. Integrated Pharmacy Research & Practice, 6, 61-69. doi: 10.2147/iprp.S104639
Devi, S., Dos Santos, R. B., Kazal, I., Leon, L., Ram, S., Wu, M., & Braund, R. (2008). Complementary medicine: What is the evidence? New Zealand Pharmacy, 28(1). doi: 10.1016/j.ejps.2008.01.013
Braund, R., Hook, S., & Medlicott, N. J. (2007). The role of topical growth factors in chronic wounds. Current Drug Delivery, 4, 195-204.
Braund, R., & Abbott, J. H. (2007). Analgesic recommendations when treating musculoskeletal sprains and strains. New Zealand Journal of Physiotherapy, 35(2), 54-60.
Braund, R. (2006). Should NSAIDs be routinely used in the treatment of sprains and strains? Pharmaceutical Journal, 276, 655-656.
Braund, R. (2001). Proceedings of the 157th and 158th scientific meetings of the Otago Medical School Research Society. New Zealand Medical Journal, 114, 454-457.
